The AI Trade Keeps on Giving as Cerebras, Nvidia & Market Indexes Soar

"The AI Trade Keeps on Giving as Cerebras, Nvidia & Market Indexes Soar" Eric Newcomer | May 15, 2026

---

1. Key Themes

🔥 Theme 1: The AI IPO Window Is Wide Open — and Frothy

The Cerebras IPO is a landmark signal that public markets are hungry for AI exposure at almost any price. The stock opened at $185, surged to $385 intraday, and closed at $311 — delivering a $95 billion market cap on debut day.

"Cerebras's powerful debut speaks to the very frothy markets and the insatiable investor appetite for AI ahead of the anticipated debuts of SpaceX later this year and Anthropic and OpenAI in 2027."

This sets a clear precedent and pressure for the next wave of AI unicorns to follow suit.

---

🔥 Theme 2: AI Inference Is the New Battleground for Chip Makers

The article identifies a structural shift in AI compute demand — from training to inference — and Cerebras benefited directly from it.

"As AI usage picked up post-ChatGPT and AI inference became the name of the game, Cerebras' wafer chips proved more efficient than Nvidia's GPUs for the task. As more labs needed these inference-specific chips to power existing user queries rather than just training runs, demand shot through the roof."

This suggests a durable investment theme: companies purpose-built for inference efficiency (not just raw training compute) may be structurally advantaged going forward.

---

🔥 Theme 3: Founder Track Records Are the Primary VC Signal in Hard Tech

The Cerebras story underscores that deep relationships and prior exits are the primary unlock for financing in capital-intensive hardware bets. Benchmark's entry came through a Stanford classmate connection; Eclipse's came through a legendary semiconductor GP's prior backing.

"Peter Fenton had been business school classmates with Feldman at Stanford, and he forwarded his colleague Vishria the pitch for a new kind of chip architecture... at Eclipse, Susan had followed the Cerebras team since his fellow GP Pierre Lamond, the legendary veteran of Fairchild Semiconductor, had backed them at SeaMicro."

For investors in hard tech, the lesson is clear: bet on proven operator-founder teams who've already delivered exits, even when the technology looks niche.

---

🔥 Theme 4: Enterprise AI Competitive Dynamics Are Shifting Away from OpenAI

The newsletter's headline data point — Anthropic topping OpenAI in enterprise usage per Ramp — signals that enterprise AI is increasingly competitive and OpenAI's market leadership is no longer a foregone conclusion.

"Anthropic tops OpenAI in enterprise usage for the first time, per Ramp."

Combined with OpenAI's internal leadership questions (see Contrarian Perspectives), this creates strategic risk for investors pricing OpenAI as the singular winner.

---

🔥 Theme 5: The AI Capital Cycle Is Accelerating Across the Stack

The newsletter's "Week in Short" section reveals a torrent of large funding rounds across defense AI, biotech AI, and AGI-adjacent companies in the same week — Anduril ($5B), Isomorphic Labs ($2.1B), and Recursive Superintelligence ($650M).

"Anduril scores $5 billion. Isomorphic Labs brings in $2.1 billion. Recursive Superintelligence debuts, with $650 million."

This suggests the AI investment cycle is now broad-based, spanning defense, life sciences, and frontier AI — not concentrated in a single sector.

---

2. Contrarian Perspectives

⚡ Perspective 1: A Legal Win for OpenAI May Not Signal Long-Term Stability — Altman's Credibility Remains a Liability

The consensus framing is that OpenAI is winning the Musk lawsuit. But the article surfaces a more uncomfortable truth: even a clean legal victory doesn't resolve the deeper credibility crisis around Sam Altman.

"Musk's side effectively highlighted the persistent and widespread doubts about Altman's credibility... five different people who'd testified in the case said he wasn't a trustworthy person (Helen Toner, Tasha McCauley, Ilya Sutskever, Mira Murati, and Musk)."

The article also notes that Altman's conflicts of interest have attracted formal Congressional scrutiny:

"Altman's conflicts of interest have been enough to warrant a letter from the House Oversight Committee demanding more information."

For investors, this is a governance risk embedded in the world's most valuable AI company — and it is distinct from and potentially more durable than any single lawsuit outcome.

---

⚡ Perspective 2: Nvidia's 20% Surge While a Competitor IPOs Defies Traditional Market Logic

Conventional wisdom holds that a well-capitalized competitor IPO in the same chip space would pressure the incumbent. The opposite happened.

"The debut came on a day when the Nasdaq and S&P indexes both registered fresh all-time highs, driven largely by unprecedented gains in a chip sector that's been super-charged by AI. Notably, Nvidia is up 20% in the last 10 days, even though Cerebras is a direct competitor."

This suggests that AI chip demand is currently so vast that the market is pricing it as an expanding pie — not a zero-sum competition. However, it also signals potential overexuberance: the market may be rewarding category exposure rather than competitive differentiation.

---

⚡ Perspective 3: Early-Stage, Patient Conviction in Hardware Generates Outlier Multiples That Growth Funds Miss

The article makes a quiet but striking point about return dispersion: Foundation Capital invested only $36.8 million at inception and generated a 129x multiple. Growth-stage funds like Coatue and Altimeter, which came in during the billion-dollar rounds, didn't even make the 5% stakeholder disclosure threshold by IPO.

"Foundation Capital had a particularly impressive return on its investment: the firm put in only $36.8 million, which at Thursday's closing price would be a 129x multiple... Coatue and Altimeter were big growth investors but no longer make the 5% stakeholder cut off for the 2026 S-1."

The implication: in category-defining AI infrastructure companies, early conviction at the seed/Series A stage delivers irreplaceable returns that later-stage capital cannot replicate — even with larger check sizes.

---

3. Companies Identified

---

4. People Identified

---

5. Operating Insights

💡 Insight 1: Customer Concentration Is Acceptable in Early AI Infrastructure — But Must Be Actively De-risked Before IPO

Cerebras's first IPO attempt failed explicitly because of over-reliance on a single foreign customer (G42). The company systematically diversified to add Amazon and OpenAI before its successful public debut.

"Susan at Eclipse helped Cerebras land G42, and later Amazon and OpenAI as big customers for Cerebras, which helped the firm slightly diversify its customer base after the cancelled 2024 IPO. Its customer concentration remains high, but if the pop on Thursday is any indication, investors will take any exposure to AI they can get at the moment, risks be damned."

Takeaway for operators: Investor tolerance for concentration risk is cyclically elevated right now — but don't mistake that for structural acceptance. The first IPO failure was a direct result of single-customer dependence. Founders in AI infrastructure should pursue strategic customer diversification as a board-level priority before any liquidity event.

---

💡 Insight 2: For Succession Planning, Board Members Who Perform Well Under Adversarial Scrutiny Become Internal CEO Candidates

The article surfaces an underappreciated dynamic: Bret Taylor's composed, well-informed testimony in a high-stakes public trial elevated him as a credible CEO candidate in the eyes of those watching — without any formal succession process.

"He was calm, confident, and well informed. He parried Musk's lawyers' questions about Altman's firing and why he chose to join the board... Taylor's name has been casually bandied about as a potential OpenAI CEO, but this was the first time it seemed real."

Takeaway for operators and board members: In high-profile companies, public performance moments — litigation, congressional testimony, earnings calls — function as live auditions for leadership. Boards should be intentional about which members they place in high-visibility, high-pressure settings.

---

6. Overlooked Insights

🔍 Insight 1: OpenAI's Cerebras Stake Creates a Structural Conflict of Interest With Nvidia

The article notes that OpenAI will own 11% of Cerebras after buying billions in compute — making OpenAI both a customer of and a significant equity holder in a direct Nvidia competitor. This relationship is largely underreported in the context of AI chip market dynamics.

"The ChatGPT maker would eventually get 11% of Cerebras after buying billions of dollars in compute capacity over the next few years."

As OpenAI prepares for its own IPO, this cross-ownership creates both a financial incentive to route compute away from Nvidia and a potential governance question: can OpenAI credibly claim neutrality in chip vendor selection when it has a billion-dollar equity stake in one vendor?

---

🔍 Insight 2: The Gallup Poll Showing Deep Public Opposition to Data Centers Has Not Been Absorbed Into AI Investment Discussions

Buried in the "Week in Short" summary is a Gallup finding that may be the most significant long-duration risk to the AI infrastructure investment thesis that no one is currently pricing in.

"The Gallup poll shows Americans' deep dislike of data centers."

As AI capex accelerates — with companies like Anduril, Cerebras, and the hyperscalers requiring massive physical infrastructure buildout — local and federal permitting, zoning, and political opposition to data centers could become a binding constraint on the entire sector's growth timeline. This is a political and regulatory risk that currently sits outside the mainstream AI investment conversation.